Acuis Daily is written by AI based on official sources. It may contain errors or omissions. Acuis Daily is for information purposes only. It is not legal or professional advice. Always check the official source before relying on an entry.
6 Nov 2026
/
Commission
/
Implementing rule
Commission drafts marketing authorisation for ADCOMFO
The draft implementing decision would grant marketing authorisation for ADCOMFO (omalizumab), a medicinal product for human use, under Regulation (EC) No 726/2004.
Importance
Noteworthy
Lenses
Regulatory
Why it matters
The draft concerns authorisation of a human medicine and is relevant to pharmaceutical regulatory specialists.
Institutions
CommissionStanding Committee on medicinal products for human use
Audience
Regulatory affairs teams
Tags
Health
Sectors
Pharmaceuticals
References
- Comitology meeting: CMTD(2026)1928